Close
Novotech
Jabsco PureFlo 21 Single Use

Japan Aims For 1 Million Boosters A Day To Fight COVID-19

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Drug Manufacturing Deals Shift to Europe Despite Tariffs

Biopharma companies are continuing to redirect production strategies toward...

DeepCyte Raises $1.5M funding to Advance AI Drug Toxicology

DeepCyte, a techbio company focused on advancing AI Drug...

Hypercon Technology Deal Signed between Halozyme and Vertex

Halozyme Therapeutics has entered into a global exclusive partnership...
- Advertisement -

Fumio Kishida, the Japanese Prime Minister, has recently gone on record to say that he is looking to speed up the country’s COVID-19 booster shots to 1 million a day by the end of February. This figure will be double the pace of what the country is currently doing as of now.

At a televised parliamentary meeting of the budget committee, Kishida said that he has instructed all his ministers to work with local authorities in order to speed up the inoculations as much as possible. Notably, the nationwide coronavirus infection surpassed 100,000 last Saturday for the first time. Most of the regions in Japan are under infection control measures to try to curb the Omicron variant, which has particularly spread in areas where fewer than 5% of the population have received the booster shots. Capital Tokyo and 12 out of the 47 prefectures in the country are on the verge of extending the virus curbs for another three weeks.

Latest stories

Related stories

Drug Manufacturing Deals Shift to Europe Despite Tariffs

Biopharma companies are continuing to redirect production strategies toward...

DeepCyte Raises $1.5M funding to Advance AI Drug Toxicology

DeepCyte, a techbio company focused on advancing AI Drug...

Hypercon Technology Deal Signed between Halozyme and Vertex

Halozyme Therapeutics has entered into a global exclusive partnership...

Gilead Advances ADC Pipeline Expansion with $3B Tubulis Deal

Gilead Sciences has agreed to acquire Germany-based Tubulis in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »